专题：Myeloproliferative Neoplasms: Diagnosis and Treatment

This cluster of papers focuses on the molecular pathogenesis, diagnosis, treatment, and prognosis of myeloproliferative disorders such as polycythemia vera, essential thrombocythemia, and myelofibrosis. It covers topics such as JAK2 and CALR mutations, prognostic scoring systems, ruxolitinib therapy, hematologic response, leukemic transformation, and stem cell transplantation.
最新文献
Identification of Hepatic-like EPO as a Cause of Polycythemia

article Full Text OpenAlex

Tumor-Infiltrating Clonal Hematopoiesis

article Full Text OpenAlex

Comparison of Prophylactic and Therapeutic Doses of Anticoagulation for Acute Chest Syndrome in Sickle Cell Disease: The TASC Randomized Clinical Trial

article Full Text OpenAlex

Clinicopathologic characteristics and outcomes of patients with clonal hematopoiesis who progress to myeloid neoplasms

article Full Text OpenAlex

Prognostic Validation of the International Consensus (ICC) Re‐Classification of Acute Myeloid Leukemia With Myelodysplasia‐Related Changes (AML‐MRC) Into Genetic Subcategories

editorial Full Text OpenAlex

Modeling ANKRD26 5’-UTR mutation-related thrombocytopenia in zebrafish

article Full Text OpenAlex

NEWLY DIAGNOSED ESSENTIAL THROMBOCYTHEMIA LEADING TO CARDIOGENIC SHOCK: A CASE REPORT

article Full Text OpenAlex

Cytogenetic abnormalities in polycythemia vera: phenotypic correlates and prognostic relevance in 669 informative cases

article Full Text OpenAlex

Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement

article Full Text OpenAlex

Malignant JAK-signaling: at the interface of inflammation and malignant transformation

review Full Text OpenAlex

近5年高被引文献
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

review Full Text OpenAlex 2603 FWCI173.903

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

article Full Text OpenAlex 1805 FWCI423.079

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

article Full Text OpenAlex 1696 FWCI396.505

The JAK/STAT signaling pathway: from bench to clinic

review Full Text OpenAlex 1487 FWCI44.798

Acute myeloid leukemia: current progress and future directions

review Full Text OpenAlex 546 FWCI23.5

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

article Full Text OpenAlex 502 FWCI77.706

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

article Full Text OpenAlex 449 FWCI31.898

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease

article Full Text OpenAlex 363 FWCI59.105

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease

article Full Text OpenAlex 345 FWCI54.49

Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia

article Full Text OpenAlex 332 FWCI78.326